Visnadine: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Drugbox | Watchedfields = changed | verifiedrevid = 443998859 | IUPAC_name = (9''R'',10''R'')-10-(acetyloxy)-8,8-dimethyl-2-oxo-9,10-dihydro-2''H'',8''H''-pyrano[2,3-''f'']c..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 41: | Line 41: | ||
| molecular_weight = 388.41 g/mol | | molecular_weight = 388.41 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Visnadine''' (or '''visnadin''') is a natural [[vasodilator]].<ref>{{cite journal|last=Durate|first=J|coauthors=Vallejo I, Pérez-Vizcaino F, Jiménez R, Zarzuelo A, Tamargo J|date=1997|title=Effects of visnadine on rat isolated vascular smooth muscles. .|journal=Planta Med|publisher=Thieme Medical Publishers|volume=63|issue=3|pages=233–6|issn=1439-0221|url=http://www.thieme-connect.de/ejournals/abstract/plantamedica/doi/10.1055/s-2006-957660|doi=10.1055/s-2006-957660|pmid=9225605}}</ref> It was first isolated from [[Ammi visnaga|bishop's weed]] (''Ammi visnaga''), a plant indigenous to the Mediterranean region which has been used for centuries in Egypt as a spasmolytic.<ref>{{cite journal | title = Constitution of Samidin, Dihydrosamidin and Visnadin | author = Eric Smith, Norman Hosansky, W. G. Bywater, and Eugene E. van Tamelen | journal = J. Am. Chem. Soc. | year = 1957 | volume = 79 | issue = 13 | pages = 3534–3540 | doi = 10.1021/ja01570a062}}</ref> | '''Visnadine''' (or '''visnadin''') is a natural [[vasodilator]].<ref>{{cite journal|last=Durate|first=J|coauthors=Vallejo I, Pérez-Vizcaino F, Jiménez R, Zarzuelo A, Tamargo J|date=1997|title=Effects of visnadine on rat isolated vascular smooth muscles. .|journal=Planta Med|publisher=Thieme Medical Publishers|volume=63|issue=3|pages=233–6|issn=1439-0221|url=http://www.thieme-connect.de/ejournals/abstract/plantamedica/doi/10.1055/s-2006-957660|doi=10.1055/s-2006-957660|pmid=9225605}}</ref> It was first isolated from [[Ammi visnaga|bishop's weed]] (''Ammi visnaga''), a plant indigenous to the Mediterranean region which has been used for centuries in Egypt as a spasmolytic.<ref>{{cite journal | title = Constitution of Samidin, Dihydrosamidin and Visnadin | author = Eric Smith, Norman Hosansky, W. G. Bywater, and Eugene E. van Tamelen | journal = J. Am. Chem. Soc. | year = 1957 | volume = 79 | issue = 13 | pages = 3534–3540 | doi = 10.1021/ja01570a062}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Peripheral vasodilators}} | {{Peripheral vasodilators}} | ||
[[Category:Vasodilators]] | [[Category:Vasodilators]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]][[Category: | |||
Revision as of 05:01, 25 July 2014
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H24O7 |
| Molar mass | 388.41 g/mol |
| (verify) | |
|
WikiDoc Resources for Visnadine |
|
Articles |
|---|
|
Most recent articles on Visnadine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Visnadine at Clinical Trials.gov Clinical Trials on Visnadine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Visnadine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Visnadine Discussion groups on Visnadine Directions to Hospitals Treating Visnadine Risk calculators and risk factors for Visnadine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Visnadine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Visnadine (or visnadin) is a natural vasodilator.[1] It was first isolated from bishop's weed (Ammi visnaga), a plant indigenous to the Mediterranean region which has been used for centuries in Egypt as a spasmolytic.[2]
References
- ↑ Durate, J (1997). "Effects of visnadine on rat isolated vascular smooth muscles." Planta Med. Thieme Medical Publishers. 63 (3): 233–6. doi:10.1055/s-2006-957660. ISSN 1439-0221. PMID 9225605. Unknown parameter
|coauthors=ignored (help) - ↑ Eric Smith, Norman Hosansky, W. G. Bywater, and Eugene E. van Tamelen (1957). "Constitution of Samidin, Dihydrosamidin and Visnadin". J. Am. Chem. Soc. 79 (13): 3534–3540. doi:10.1021/ja01570a062.
Categories:
- Pages with script errors
- Pages with citations using unsupported parameters
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Vasodilators
- Cardiovascular Drugs
- Drug